Loeb Partners Corp
TEVA icon

Loeb Partners Corp’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Loeb Partners Corp’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-400
Closed -$6K – 265
2018
Q4 		$6K Buy
+400
New +$8.2K ﹤0.01% 247

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Loeb Partners Corp's TEVA Position: Q1 2019 in Review

Loeb Partners Corp sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2019, closing a stake of 400 shares — an estimated $6K sold.

Loeb Partners Corp first reported a position in TEVA in Q4 2018 and held it in 1 quarter. The position peaked at $6K in Q4 2018. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • Loeb Partners Corp reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 400 Teva Pharmaceutical Industries Limited shares in Q1 2019, an estimated $6K.
  • Loeb Partners Corp first reported a position in Teva Pharmaceutical Industries Limited in Q4 2018 and held it in 1 quarter.
  • Loeb Partners Corp's Teva Pharmaceutical Industries Limited position peaked at $6K in Q4 2018.
  • 522 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2019.

Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.